SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kevin kirkendall who wrote ()3/25/1999 2:05:00 PM
From: Shake-Man   of 1837
 
Ok, kids. What now?

Don't get me wrong. A double in one day is nothing to sneer at. If my other stocks would do that, I could retire really soon. I just figured that this news would shoot the stock up to at least the mid twenties. I mean, it went there in 1995 and there was nothing as big as Cenestin on the table. Will we see this stock shine in the future? If so, how long til we see it? I guess it all depends on Cenestin's sales and marketing.

It would be nice if we could get some good analyst coverage. I think that CNBC's downplaying of the drug's importance today (I didn't see, just heard about it) really put the brakes on a good possible run for today. That just sucks. I'd appreciate any opinions and feedback. Myself, I'm not settling for a price in the teens. I'm not selling til it hits at least 30 or 40. I just hope it's before I start getting gray hair.

Shake-Man, a guy who would take Cenestin if he thought it would help the stock. maybe
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext